Sera obtained from adult volunteers inoculated with genogroup II Norwalk-li
ke viruses (NLVs), Hawaii virus, and Snow Mountain virus and from patients
involved in outbreaks of gastroenteritis were tested for genogroup II NLV M
exico virus-specific immunoglobulin M (IgM) by use of a monoclonal antibody
, recombinant Mexico virus antigen (rMXV)-based IgM capture enzyme-linked i
mmunosorbent assay (ELISA). Sera from genogroup I Norwalk virus (NV)-inocul
ated volunteers and from patients involved in a genogroup I NLV outbreak we
re also tested. In sera from those infected with genogroup I NV or NLVs in
volunteer and outbreak studies, only 3 of 25 were rMXV IgM positive; in con
trast, 24 of 25 were IgM positive for recombinant NV (rNV). In sera from th
ose infected with genogroup II NLVs in volunteer and outbreak studies, 28 o
f 47 were rMXV IgM positive and none were IgM positive for rNV, showing the
specificity of each IgM test for its respective genogroup. In an outbreak
of gastroenteritis not characterized as being of viral etiology but suspect
ed to be due to NV, 7 of 13 persons had IgM responses to rMXV, whereas none
had IgM responses to rNV, thus establishing the diagnosis as genogroup II
NLV infection. The rMXV-based IgM capture ELISA developed is specific for t
he diagnosis of genogroup II NLV infections.